Abstract
The TP53 tumor suppressor gene on chromosome 17p13.1 contains 11 exons and encodes a nuclear phosphoprotein of 53 kDa, a transcription factor involved in the regulation of the cell cycle (1). Normal p53 protein functions as a cell cycle checkpoint and is involved in DNA repair and/or apoptosis (2). The p53 protein acts as a powerful transcription factor that binds to as many as 300 different promoter elements in the genome, broadly altering patterns of specific gene expression (3). Loss of normal p53 function can lead to uncontrolled cell proliferation and neoplastic transformation. A TP53 mutation, most commonly a missense mutation, may cause either a loss of tumor suppressor function or, in certain cases, a gain of oncogenic function (4–6). This functional duality may be one explanation for the high frequency of TP53 mutations in human cancer (7–10), which makes the TP53 gene especially suitable for mutational analysis. The modest size of the highly conserved TP53 gene (p53 protein contains 393 amino acids in human) is an advantage in mutation analysis. Mutations in TP53 are usually clustered within the most conserved regions in the area of exons 5–8, corresponding to the sequence-specific DNA-binding domain of the p53 protein (11,12).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Lane, D. P. and Lain, S. (2002) Therapeutic exploitation of the p53 pathway. Trends Mol. Med. 8(4), 38–42.
Vousden, K. H. (2002) Activation of the p53 tumor suppressor protein. Biochim. Biophys. Acta 1602, 47–59.
Zhao, R., Gish, K., Murphy, M., et al. (2000) Analysis of p53 regulated gene expression patterns using oligonucleotide arrays. Genes Dev. 14, 981–993.
Sigal, A. and Rotter, V. (2000) Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res. 60, 6788–6793.
van Oijen, M. G. C. T. and Slootweg, P. J. (2000) Gain-of-function mutations in the tumor suppressor gene p53. Clin. Cancer Res. 6, 2138–2145.
Guimaraes, D. P. and Hainaut, P. (2002) TP53: a key gene in human cancer. Biochimie 84, 83–93.
Hollstein, M., Sidransky, B., Vogelstein, C., et al. (1991) P53 mutations in human cancers. Science 253, 49–53.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., et al. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855–4878.
Hainaut, P., Soussi, T., Shomer, B., et al. (1997) Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acid Res. 25, 151–157.
Vähäkängas, K. H., Bennett, W. P., Castren, K., et al. (2001) P53 gene and K-ras mutations in lung cancers from former and never-smoking women. Cancer Res. 61, 4350–4356.
Levine, A. J. (1997) P53, the cellular gatekeeper for growth and division. Cell 88, 323–331.
Hainaut, P. and Vähäkangas, K. (1997) P53 as a sensor of carcinogenic exposures: mechanisms of p53 protein induction and lessons from p53 gene mutations. Pathol.-Biolog. 45, 833–844.
Borresen, A.-L., Anderson, T. I., Eyfjörd, J. E., et al. (1995) TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains. Genes Chromosomes Cancer 14, 71–75.
Valgardsdottir, R., Tryggvadottir, L., Steinarsdottir, M., et al. (1997) Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysis. APMIS 105, 121–130.
Huang, C., Taki, T., Adachi, M., et al. (1998) Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer. Oncogene 16, 2469–2477.
Orita, M., Iwahana, H., Kanazawa, H., et al. (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA 86, 2766–2770.
Hayashi, K. (1992) PCR-SSCP: a method for detection of mutations. GATA 9, 73–92.
Hayashi, K. and Yandell, D. W. (1993) How sensitive is PCR-SSCP? Hum. Mutat. 2, 338–346.
Glavac, D. and Dean, M. (1993) Optimization of the single-strand conformation polymorphism (SSCP) technique for detection of point mutations. Hum. Mutat. 2, 404–414.
Moyret, C., Theillet, C., Puig, P. L., et al. (1994) Relative efficiency of denaturing gradient gel electrophoresis and single-strand conformation polymorphism in the detection of mutations in exon 5 to 8 of the p53 gene. Oncogene 9, 1739–1743.
Welsh, J. A., Castren, K., and Vahakangas, K. (1997) Single-strand conformation polymorphism analysis to detect p53 mutations: characterization and development of controls. Clin. Chem. 43, 2251–2255.
Sheffield, V. C., Cox, D. R., Lerman, L. S., et al. (1989) Attachment of a 40-base-pair G + C-rich sequence (GC-lamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc. Natl. Acad. Sci. USA 86, 232–236.
Meinhold-Heerlein, I., Ninci, E., Ikenberg, H., et al. (2001) Evaluation of methods to detect p53 mutations in ovarian cancer. Oncology 60, 176–188.
Ryu, J.-W., Lee, M.-C., and Jang, W.-C. (2000) Detecting p53 gene mutation of breast cancer and defining differences between silver staining PCR-SSCP and immunohistochemical staining. J. Korean Med. Sci. 15, 73–77.
Pinheiro, N. A., Moura, R. P., Monteiro, E., et al. (1999) Detection of point mutations by non-isotopic single strand conformation polymorphism. Brazil J. Med. Biol. Res. 32, 55–58.
Vähäkangas, K. H., Castren, K., and Welsh, J. A. (2000) Single-strand conformation polymorphism analysis of mutations in exons 4–8 of the TP53 gene, in Methods in Molecular Medicine, Volume 49: Molecular Pathology Protocols (Killeen, A. A., ed.), Humana, Totowa, NJ, pp. 15–27.
Wikman, F. P., Lu, M.-L., Thykjaer, T., et al. (2000) Evaluation of the performance of a p53 sequencing microarray chip using 140 previously sequenced bladder tumor samples. Clin. Chem. 46, 1555–1561.
Vähäkangas, K. H., Samet, J. M., Metcalf, R. A., et al. (1992) Mutations of the p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet 339, 576–580.
Shi, M. M. (2001) Enabling large-scale pharmacogenetic studies by high-throughput mutation detection and genotyping technologies. Clin. Chem. 47, 164–172.
Worsham, M. J., Pals, G., Raju, U., et al. (2002) Establishing a molecular continuum in breast cancer: DNA microarrays and benign breast disease. Cytometry 47, 56–59.
Schaefer K. L., Wai, D., Poremba, C., et al. (2002) Analysis of TP53 mutations in pediatric tumor patients using microarray-based sequencing technology. Med. Pediatr. Oncol. 38(4), 247–253.
Castren, K., Ranki, A., Welsh, J., et al. (1998a) Infrequent p53 mutations in arsenic-related skin lesions. Oncol. Res. 10, 475–482.
Chaubert, P., Beautista, D., and Benhattar J. (1993) An improved method for rapid screening of DNA mutations by nonradioactive single-strand conformational polymorphism procedure. Biotechniques 15, 586.
Cheng, J. and Haas, M. (1992) Sensitivity of detection of heterozygous point mutations in p53 cDNAs by direct PCR sequencing. PCR Methods Appl. 1, 199–201.
Wu, J. K., Ye, Z., and Darras, B. T. (1993) Sensitivity of single-strand conformation polymorphism (SSCP) analysis in detecting p53 point mutations in tumours with mixed cell populations. Am. J. Hum. Genet. 52, 1273–1275.
Conway, K., Edmiston, S. N., Cui, L., et al. (2002) Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. Cancer Res. 62, 1987–1995.
Mizusawa, S., Nishimura, S., and Seela, F. (1986) Improvement of the dideoxy chain termination method of DNA sequencing by use of deoxy-7-deazaguanosine triphosphate in place of dGTP. Nucleic Acids Res. 14, 1319–1324.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Hakkarainen, J., Welsh, J.A., Vähäkangas, K.H. (2004). TP53 Mutation Detection by SSCP and Sequencing. In: Roulston, J.E., Bartlett, J.M.S. (eds) Molecular Diagnosis of Cancer. Methods in Molecular Medicine, vol 97. Humana Press. https://doi.org/10.1385/1-59259-760-2:191
Download citation
DOI: https://doi.org/10.1385/1-59259-760-2:191
Publisher Name: Humana Press
Print ISBN: 978-1-58829-160-8
Online ISBN: 978-1-59259-760-4
eBook Packages: Springer Protocols